#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma stage II Adenocarcinoma pancreas Mucopolysaccharidosis III Lennox-Gastaut syndrome Henoch-Schonlein purpura Adenoid cystic carcinoma Myelofibrosis Small intestine adenocarcinoma Chronic lymphocytic leukaemia refractory Thrombocytopenia Primary immunodeficiency syndrome Dedifferentiated liposarcoma Fibrosarcoma Trigeminal neuralgia Hepatic cirrhosis More trials…

    Learn about Rare Diseases

    Nephroblastoma – Basic Information Marginal zone lymphoma refractory – Treatment Mucous membrane pemphigoid – Treatment Angelman’s syndrome Inclusion body myositis – Diagnostics CADASIL X-linked lymphoproliferative syndrome – Basic Information Nodal marginal zone B-cell lymphoma – Treatment Pemphigus Factor VIII deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Autologous Chondrocytes Omo-103 Dnth103 Lisocabtagene Maraleucel Pilocarpine Nitrate Ivospemin Ergocalciferol Oregovomab 18F-Fludarabine Romidepsin Azathioprine F770/05 Dcc-3116 ANTIMETABOLITES SECRETIN SYNTHETIC HUMAN Csm-Gw FG001 Cipepofol Nms-03592088 Losartan Potassium More therapies…

    Learn about Your Condition

    Ocular myasthenia Cardiac failure congestive Cutaneous T-cell lymphoma Naevoid melanoma Inner ear disorder Postpartum haemorrhage Colour blindness Frontotemporal dementia Fibromyalgia Postprandial hypoglycaemia Erythema multiforme Red blood cell abnormality Bone sarcoma Pancreatic fistula Endometrial cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Clodronate Disodium for Patients with Painful Knee Osteoarthritis

    Recruiting

    4 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Clodronate Disodium
    Italy

  • Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Zanidatamab
    • Cisplatin
    • Durvalumab
    Belgium Czechia Finland France Germany Italy +4

  • Study on the Effects of Tedizolid and Linezolid for Patients with Suspected Lung Tuberculosis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ethambutol
    • Tedizolid Phosphate
    • Isoniazid
    France

  • Study of Azithromycin Treatment Based on Mucus Changes in Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Azithromycin Dihydrate
    France

  • Study on CLIC-1901 CAR T-cells and Tocilizumab for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B precursor type acute leukaemia
    • Follicular lymphoma
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Clic-1901 Cart
    • Tocilizumab
    Denmark

  • A Study of Vildagliptin to Prevent Diabetes in Kidney Transplant Recipients During Early Post-Transplant Period

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Vildagliptin
    France
Previous Page
1 … 338 339 340 341 342 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!